Natalizumab Completed Phase N/A Trials for Relapsing Multiple Sclerosis (RMS)

IndicationsStatusPurposePhase
CompletedNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT01070836JC Virus Antibody Study of Participants With Relapsing Forms of MS Receiving Treatment With Natalizumab